VedaLab Showcases Comprehensive Portfolio for Rapid Diagnostic Testing
Posted on 19 Nov 2025
VEDALAB SA is presenting its comprehensive portfolio of rapid tests, immunodiagnostic reagents and point-of-care (POC) technologies at MEDICA 2025. Exhibiting in Hall 1, Stand A64, the company is showcasing solutions designed for clinical laboratories, primary care settings, and supervised home testing.
VedaLab’s exhibitor profile at MEDICA 2026 highlights several key rapid test products: GLUTEN’ALARM is an immunochromatographic test for the qualitative detection of anti-tissue transglutaminase IgA antibodies associated with Gluten intolerance (celiac disease) in whole blood. STREPA’ALERT provides rapid detection of Group A Streptococcus from throat swabs for clinical and near patient use. Babycheck 1 WB, a whole blood pregnancy test, reflects the company’s experience in CE marked home use diagnostics. Additional highlighted products include URICHECK for rapid uric acid screening and VedaLab’s latex reagent line for routine serological and immunological applications.
Another major feature at the company’s booth is the EASY READER+ instrument. This POC device enables quantitative measurements from finger-prick whole blood samples using lateral flow rapid tests. The instrument includes a touchscreen interface, enhanced memory and internet-based upgrading. EASY READER+ and its associated quantitative tests are designed for use in physician offices, clinical laboratories and online pharmacy networks, as well as supervised consumer testing through diagnostic information providers.
Laboratory professionals, point-of-care coordinators and distribution partners attending MEDICA 2025 can visit Hall 1, Stand A64 to discover VedaLab's latest self-testing innovations and explore our full panel of solutions.
Related Links:
VedaLab
